Tapewire

NYSE · USD

COR

Cencora, Inc.

Export transactions ↓
Tapewire entity
2994
SEC CIK
0001140859
Parsed reports
801

Last 12 months

Inside the activity.

3 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202504
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202610
Jun 202620
Jul 202600
Aug 202601
Sep 202602
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 11, 2023 Filed May 15, 2023 21:18 UTC SaleCommon Stock 292,792 $170.77 $50,000,089.84
Disclosure

SEC source: 0000899243-23-012969 · doc4.xml · nonDerivative · entry 1

Walgreens Boots Alliance, Inc. · CIK 0001618921 · 10% owner

Walgreens Boots Alliance Holdings LLC · CIK 0001669077 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 33,366,388

F1 · kind: Represents a sale in a private transaction to the Issuer by WBA Holdings.

F7 · balance_after: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022 and May 15, 2023, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F7 · ownership.nature: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022 and May 15, 2023, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F8 · ownership.nature: These Contracts are held by Counterparty.

F9 · ownership.nature: As described in the Schedule 13D, as amended, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of Counterparty, may also be deemed to beneficially own the securities reported in this Form 4.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:03 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,499 $0.00 Strike: $77.53 $0.00
Disclosure

SEC source: 0001140859-23-000088 · wf-form4_168374897274917.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,997

Underlying: Common Stock · 10,499 shares

Expires 2024-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/15/18, 11/15/19, 11/15/20 and 11/15/21.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:03 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,499 $169.52 $1,779,790.48
Disclosure

SEC source: 0001140859-23-000088 · wf-form4_168374897274917.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 257,967

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
May 09, 2023 Filed May 10, 2023 20:03 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,499 $77.53 $813,987.47
Disclosure

SEC source: 0001140859-23-000088 · wf-form4_168374897274917.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
May 01, 2023 Filed May 3, 2023 20:05 UTC GrantCommon Stock 188 $166.79 $31,356.52
Disclosure

SEC source: 0001140859-23-000086 · wf-form4_168314429789627.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,918

F1 · shares: Shares of common stock issued in lieu of $31,250 quarterly cash retainer.

Read SEC document
April 11, 2023 Filed Apr 13, 2023 20:10 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,499 $0.00 Strike: $77.53 $0.00
Disclosure

SEC source: 0001140859-23-000079 · wf-form4_168141659270360.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,496

Underlying: Common Stock · 10,499 shares

Expires 2024-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/15/18, 11/15/19, 11/15/20 and 11/15/21.

Read SEC document
April 11, 2023 Filed Apr 13, 2023 20:10 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,499 $167.34 $1,756,902.66
Disclosure

SEC source: 0001140859-23-000079 · wf-form4_168141659270360.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 257,967

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
April 11, 2023 Filed Apr 13, 2023 20:10 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,499 $77.53 $813,987.47
Disclosure

SEC source: 0001140859-23-000079 · wf-form4_168141659270360.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 20:05 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,499 $0.00 Strike: $77.53 $0.00
Disclosure

SEC source: 0001140859-23-000076 · wf-form4_167891071840880.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,995

Underlying: Common Stock · 10,499 shares

Expires 2024-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/15/18, 11/15/19, 11/15/20 and 11/15/21.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 20:05 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,499 $150.00 $1,574,850.00
Disclosure

SEC source: 0001140859-23-000076 · wf-form4_167891071840880.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,967

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 20:05 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,499 $77.53 $813,987.47
Disclosure

SEC source: 0001140859-23-000076 · wf-form4_167891071840880.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:17 UTC GrantCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000069 · wf-form4_167873865637500.xml · nonDerivative · entry 1

HYLE KATHLEEN W · CIK 0001117310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,970

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F2 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. In addition to the 1,334 newly awarded restricted stock units and 17,845 shares of common stock, the total reported in Column 5 includes 2,791 unvested restricted stock units previously reported in Table II.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:20 UTC GrantCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000073 · wf-form4_167873882977168.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,730

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F2 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. In addition to the 1,334 newly awarded restricted stock units and 4,605 shares of common stock, the total reported in Column 5 includes 2,791 unvested restricted stock units previously reported in Table II.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:19 UTC GrantCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000071 · wf-form4_167873873562161.xml · nonDerivative · entry 1

McGee Henry Wadsworth III · CIK 0001307634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,479

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F2 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. In addition to the 1,334 newly awarded restricted stock units and 15,014 shares of common stock, the total reported in Column 5 includes 4,131 restricted stock units previously reported in Table II, of which 2,791 are unvested restricted stock units and 1,340 are vested restricted stock units with deferred share delivery.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:19 UTC GrantCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000072 · wf-form4_167873878321379.xml · nonDerivative · entry 1

Miller Redonda · CIK 0001891346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,562

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:18 UTC GrantCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000070 · wf-form4_167873869355138.xml · nonDerivative · entry 1

Kim Lorence H. · CIK 0001643746 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant. Delivery of vested shares deferred until 3/10/2028.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant. Delivery of vested shares deferred until 3/10/2028.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:16 UTC GrantCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000068 · wf-form4_167873860099611.xml · nonDerivative · entry 1

GREENBERG LON R · CIK 0001234234 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,879

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant. Delivery of vested shares deferred until 1/15/2028.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant. Delivery of vested shares deferred until 1/15/2028.

F2 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. In addition to the 1,334 newly awarded restricted stock units and 15,301 shares of common stock, the total reported in Column 5 includes 8,244 restricted stock units previously reported in Table II, of which 2,791 are unvested restricted stock units and 5,453 are vested restricted stock units with deferred share delivery.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:16 UTC GrantCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000067 · wf-form4_167873855836631.xml · nonDerivative · entry 1

GOCHNAUER RICHARD W · CIK 0001214315 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,326

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F2 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. In addition to the 1,334 newly awarded restricted stock units and 20,841 shares of common stock, the total reported in Column 5 includes 4,151 restricted stock units previously reported in Table II, of which 2,791 are unvested restricted stock units and 1,360 are vested restricted stock units with deferred share delivery.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:15 UTC GrantCommon Stock 1,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000066 · wf-form4_167873851802308.xml · nonDerivative · entry 1

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,730

F1 · shares: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

F2 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. In addition to the 1,667 newly awarded restricted stock units and 14,272 shares of common stock, the total reported in Column 5 includes 2,791 unvested restricted stock units previously reported in Table II.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:14 UTC
Battaglia SilvanaExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 1,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000065 · wf-form4_167873846848067.xml · derivative · entry 3

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,211

Underlying: Common Stock · 1,211 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:14 UTC
Battaglia SilvanaExecutive Vice President
Tax withholdingCommon Stock 359 $150.00 $53,850.00
Disclosure

SEC source: 0001140859-23-000065 · wf-form4_167873846848067.xml · nonDerivative · entry 2

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,704.4522

F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 20:14 UTC
Battaglia SilvanaExecutive Vice President
Exercise / conversionCommon Stock 1,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000065 · wf-form4_167873846848067.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,063.4522

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:51 UTC Exercise / conversionRestricted Stock Units · Derivative 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000055 · wf-form4_167821867877942.xml · derivative · entry 2

HYLE KATHLEEN W · CIK 0001117310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:51 UTC Exercise / conversionCommon Stock 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000055 · wf-form4_167821867877942.xml · nonDerivative · entry 1

HYLE KATHLEEN W · CIK 0001117310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:42 UTC Exercise / conversionRestricted Stock Units · Derivative 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000053 · wf-form4_167821813946091.xml · derivative · entry 2

LONG MICHAEL J · CIK 0001186373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:42 UTC Exercise / conversionCommon Stock 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000053 · wf-form4_167821813946091.xml · nonDerivative · entry 1

LONG MICHAEL J · CIK 0001186373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,724

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:01 UTC Exercise / conversionRestricted Stock Units · Derivative 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000047 · wf-form4_167821565663356.xml · derivative · entry 2

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:01 UTC Exercise / conversionCommon Stock 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000047 · wf-form4_167821565663356.xml · nonDerivative · entry 1

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,272

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:34 UTC Exercise / conversionRestricted Stock Units · Derivative 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000051 · wf-form4_167821764356223.xml · derivative · entry 2

GOCHNAUER RICHARD W · CIK 0001214315 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:34 UTC Exercise / conversionCommon Stock 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000051 · wf-form4_167821764356223.xml · nonDerivative · entry 1

GOCHNAUER RICHARD W · CIK 0001214315 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,841

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:22 UTC Exercise / conversionRestricted Stock Units · Derivative 2,300 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000049 · wf-form4_167821694240137.xml · derivative · entry 2

HENNEY JANE E MD · CIK 0001191522 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant

Read SEC document
March 05, 2023 Filed Mar 7, 2023 19:22 UTC Exercise / conversionCommon Stock 2,300 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000049 · wf-form4_167821694240137.xml · nonDerivative · entry 1

HENNEY JANE E MD · CIK 0001191522 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,685

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant

Read SEC document
March 05, 2023 Filed Mar 7, 2023 18:20 UTC Exercise / conversionRestricted Stock Units · Derivative 2,012 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001140859-23-000045 · wf-form4_167821323787678.xml · derivative · entry 2

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 18:20 UTC Exercise / conversionCommon Stock 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000045 · wf-form4_167821323787678.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,605

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 18:14 UTC Exercise / conversionRestricted Stock Units · Derivative 2,012 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001140859-23-000043 · wf-form4_167821288166419.xml · derivative · entry 2

McGee Henry Wadsworth III · CIK 0001307634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 05, 2023 Filed Mar 7, 2023 18:14 UTC Exercise / conversionCommon Stock 2,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000043 · wf-form4_167821288166419.xml · nonDerivative · entry 1

McGee Henry Wadsworth III · CIK 0001307634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:08 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 1,838 $156.22 $287,132.36
Disclosure

SEC source: 0001140859-23-000041 · wf-form4_167787766285487.xml · nonDerivative · entry 2

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,733

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:08 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 86 $156.19 $13,432.34
Disclosure

SEC source: 0001140859-23-000041 · wf-form4_167787766285487.xml · nonDerivative · entry 1

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,571

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:06 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,499 $0.00 Strike: $77.53 $0.00
Disclosure

SEC source: 0001140859-23-000039 · wf-form4_167658153014437.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,494

Underlying: Common Stock · 10,499 shares

Expires 2024-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/15/18, 11/15/19, 11/15/20 and 11/15/21.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:06 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,499 $159.28 $1,672,280.72
Disclosure

SEC source: 0001140859-23-000039 · wf-form4_167658153014437.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,967

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:06 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,499 $77.53 $813,987.47
Disclosure

SEC source: 0001140859-23-000039 · wf-form4_167658153014437.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/13/2022 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/16/2022.

Read SEC document
February 07, 2023 Filed Feb 9, 2023 21:06 UTC
Krikorian LazarusSVP & Chief Accounting Officer
SaleCommon Stock 5,711 $155.82 $889,888.02
Disclosure

SEC source: 0001140859-23-000037 · wf-form4_167597676222522.xml · nonDerivative · entry 1

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,732

F1 · balance_after: Includes 118 shares of common stock previously purchased under the Company's Employee Stock Purchase Plan in an exempt transaction.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:12 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 5,835 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001140859-23-000035 · wf-form4_167580433019959.xml · derivative · entry 3

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,835 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Special retention grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Special retention grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Special retention grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Special retention grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:12 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Tax withholdingCommon Stock 1,683 $156.73 $263,776.59
Disclosure

SEC source: 0001140859-23-000035 · wf-form4_167580433019959.xml · nonDerivative · entry 2

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,325

F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:12 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Exercise / conversionCommon Stock 5,835 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000035 · wf-form4_167580433019959.xml · nonDerivative · entry 1

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Special retention grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:07 UTC
Campbell Elizabeth SExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 4,668 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001140859-23-000033 · wf-form4_167580400213481.xml · derivative · entry 3

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,668 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration and vests 100% on 2/3/2023.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on 2/3/2023.

F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration and vests 100% on 2/3/2023.

F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration and vests 100% on 2/3/2023.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:07 UTC
Campbell Elizabeth SExecutive Vice President
Tax withholdingCommon Stock 1,486 $156.73 $232,900.78
Disclosure

SEC source: 0001140859-23-000033 · wf-form4_167580400213481.xml · nonDerivative · entry 2

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,088.408

F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:07 UTC
Campbell Elizabeth SExecutive Vice President
Exercise / conversionCommon Stock 4,668 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000033 · wf-form4_167580400213481.xml · nonDerivative · entry 1

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,574.408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on 2/3/2023.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:10 UTC GrantCommon Stock 228 $0.00 $0.00
Disclosure

SEC source: 0001140859-23-000031 · wf-form4_167545862619407.xml · nonDerivative · entry 1

Miller Redonda · CIK 0001891346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:05 UTC GrantCommon Stock 194 $161.05 $31,243.70
Disclosure

SEC source: 0001140859-23-000029 · wf-form4_167545828647695.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,593

F1 · shares: Shares of common stock issued in lieu of $31,250 quarterly cash retainer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.